Feeds › Insider trades
Insider trades
Open-market buys and sells by officers, directors and 10% owners, from SEC Form 4. Usually filed within two business days.
About this data
- What it is
- When a company's officers, directors or owners of more than 10% buy or sell its stock, they must report the trade to the SEC on Form 4. This feed shows purchases and sales on the open market; stock grants, option exercises and shares withheld for tax are left out.
- Who files it
- The insider, usually through the company, within two business days of the trade.
- How current
- We collect new filings throughout the day on SEC business days.
- Worth knowing
- Sales are often routine: insiders sell to diversify, to pay taxes, or under a 10b5-1 plan set up months in advance. A purchase with their own money is less common, which is why many investors pay closer attention to it.
All of this comes from public filings.
Source and freshness · Information, not investment advice (disclaimer).
Open-market trades per day, last 30 days
Purchases Sales
By trade date. Insiders have two business days to file, so the most recent days fill in later.
Latest open-market insider trades
Showing: ticker RYTM
| Traded | Insider | Company | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Sep 14, 2026 | David P. Meeker President and CEO, Director | RYTM Rhythm Pharmaceuticals, Inc. | Sale | 2,300 | $105.19 | $241.9K Sale | Form 4 ↗ |
| Sep 14, 2026 | David P. Meeker President and CEO, Director | RYTM Rhythm Pharmaceuticals, Inc. | Sale | 1,817 | $104.55 | $190.0K Sale | Form 4 ↗ |
| Sep 14, 2026 | David P. Meeker President and CEO, Director | RYTM Rhythm Pharmaceuticals, Inc. | Sale | 8,698 | $103.43 | $899.6K Sale | Form 4 ↗ |
| Sep 14, 2026 | David P. Meeker President and CEO, Director | RYTM Rhythm Pharmaceuticals, Inc. | Sale | 30,746 | $102.35 | $3.1M Sale | Form 4 ↗ |
| Sep 14, 2026 | David P. Meeker President and CEO, Director | RYTM Rhythm Pharmaceuticals, Inc. | Sale | 6,439 | $101.75 | $655.2K Sale | Form 4 ↗ |
| Aug 31, 2026 | Hunter C. Smith Chief Financial Officer | RYTM Rhythm Pharmaceuticals, Inc. | Sale | 28,188 | $106.20 | $3.0M Sale | Form 4 ↗ |
| Aug 31, 2026 | Hunter C. Smith Chief Financial Officer | RYTM Rhythm Pharmaceuticals, Inc. | Sale | 11,514 | $105.37 | $1.2M Sale | Form 4 ↗ |
| Aug 31, 2026 | Hunter C. Smith Chief Financial Officer | RYTM Rhythm Pharmaceuticals, Inc. | Sale | 23,072 | $104.59 | $2.4M Sale | Form 4 ↗ |
| Aug 13, 2026 | Joseph Shulman Chief Technical Officer | RYTM Rhythm Pharmaceuticals, Inc. | Sale | 5,079 | $119.75 | $608.2K Sale | Form 4 ↗ |
| Aug 13, 2026 | Alastair Garfield Chief Scientific Officer | RYTM Rhythm Pharmaceuticals, Inc. | Sale | 800 | $119.17 | $95.3K Sale | Form 4 ↗ |
| Aug 13, 2026 | Alastair Garfield Chief Scientific Officer | RYTM Rhythm Pharmaceuticals, Inc. | Sale | 3,400 | $118.28 | $402.2K Sale | Form 4 ↗ |
| Aug 13, 2026 | Alastair Garfield Chief Scientific Officer | RYTM Rhythm Pharmaceuticals, Inc. | Sale | 1,556 | $117.08 | $182.2K Sale | Form 4 ↗ |
| Aug 13, 2026 | Alastair Garfield Chief Scientific Officer | RYTM Rhythm Pharmaceuticals, Inc. | Sale | 2,007 | $116.11 | $233.0K Sale | Form 4 ↗ |
| Aug 13, 2026 | Jennifer Kayden Lee EVP, Head of North America | RYTM Rhythm Pharmaceuticals, Inc. | Sale | 75,834 | $117.38 | $8.9M Sale | Form 4 ↗ |
| Aug 12, 2026 | Yann Mazabraud EVP, Head of International | RYTM Rhythm Pharmaceuticals, Inc. | Sale | 17,319 | $117.47 | $2.0M Sale | Form 4 ↗ |
| Aug 12, 2026 | Yann Mazabraud EVP, Head of International | RYTM Rhythm Pharmaceuticals, Inc. | Sale | 18,208 | $116.49 | $2.1M Sale | Form 4 ↗ |
| Aug 12, 2026 | Yann Mazabraud EVP, Head of International | RYTM Rhythm Pharmaceuticals, Inc. | Sale | 14,568 | $115.43 | $1.7M Sale | Form 4 ↗ |
| Aug 12, 2026 | Yann Mazabraud EVP, Head of International | RYTM Rhythm Pharmaceuticals, Inc. | Sale | 3,605 | $114.70 | $413.5K Sale | Form 4 ↗ |
| Aug 12, 2026 | Yann Mazabraud EVP, Head of International | RYTM Rhythm Pharmaceuticals, Inc. | Sale | 1,000 | $112.86 | $112.9K Sale | Form 4 ↗ |
| Aug 12, 2026 | Yann Mazabraud EVP, Head of International | RYTM Rhythm Pharmaceuticals, Inc. | Sale | 2,300 | $111.80 | $257.1K Sale | Form 4 ↗ |
| Jun 22, 2026 | Lynn A. Tetrault Director | RYTM Rhythm Pharmaceuticals, Inc. | Sale | 37,000 | $100.32 | $3.7M Sale | Form 4 ↗ |
| May 15, 2026 | Christopher Paul German Corporate Controller & CAO | RYTM Rhythm Pharmaceuticals, Inc. | Sale | 4,643 | $92.21 | $428.1K Sale | Form 4 ↗ |
| Mar 4, 2026 | Christopher Paul German Corporate Controller & CAO | RYTM Rhythm Pharmaceuticals, Inc. | Sale | 5,614 | $89.56 | $502.8K Sale | Form 4 ↗ |
| Feb 19, 2026 | Hunter C. Smith Chief Financial Officer | RYTM Rhythm Pharmaceuticals, Inc. | Sale | 585 | $103.28 | $60.4K Sale | Form 4 ↗ |
| Feb 19, 2026 | Hunter C. Smith Chief Financial Officer | RYTM Rhythm Pharmaceuticals, Inc. | Sale | 800 | $102.10 | $81.7K Sale | Form 4 ↗ |
| Feb 19, 2026 | Hunter C. Smith Chief Financial Officer | RYTM Rhythm Pharmaceuticals, Inc. | Sale | 1,692 | $100.92 | $170.8K Sale | Form 4 ↗ |
| Feb 19, 2026 | Hunter C. Smith Chief Financial Officer | RYTM Rhythm Pharmaceuticals, Inc. | Sale | 1,308 | $100.27 | $131.2K Sale | Form 4 ↗ |
| Feb 17, 2026 | Hunter C. Smith Chief Financial Officer | RYTM Rhythm Pharmaceuticals, Inc. | Sale | 200 | $103.84 | $20.8K Sale | Form 4 ↗ |
| Feb 17, 2026 | Hunter C. Smith Chief Financial Officer | RYTM Rhythm Pharmaceuticals, Inc. | Sale | 1,069 | $103.00 | $110.1K Sale | Form 4 ↗ |
| Feb 17, 2026 | Hunter C. Smith Chief Financial Officer | RYTM Rhythm Pharmaceuticals, Inc. | Sale | 900 | $101.70 | $91.5K Sale | Form 4 ↗ |
| Feb 17, 2026 | Hunter C. Smith Chief Financial Officer | RYTM Rhythm Pharmaceuticals, Inc. | Sale | 200 | $100.52 | $20.1K Sale | Form 4 ↗ |
| Feb 17, 2026 | Hunter C. Smith Chief Financial Officer | RYTM Rhythm Pharmaceuticals, Inc. | Sale | 1,200 | $99.42 | $119.3K Sale | Form 4 ↗ |
| Feb 12, 2026 | Hunter C. Smith Chief Financial Officer | RYTM Rhythm Pharmaceuticals, Inc. | Sale | 100 | $100.10 | $10.0K Sale | Form 4 ↗ |
| Feb 12, 2026 | Hunter C. Smith Chief Financial Officer | RYTM Rhythm Pharmaceuticals, Inc. | Sale | 800 | $98.99 | $79.2K Sale | Form 4 ↗ |
| Feb 12, 2026 | Hunter C. Smith Chief Financial Officer | RYTM Rhythm Pharmaceuticals, Inc. | Sale | 400 | $97.67 | $39.1K Sale | Form 4 ↗ |
| Feb 12, 2026 | Hunter C. Smith Chief Financial Officer | RYTM Rhythm Pharmaceuticals, Inc. | Sale | 292 | $96.26 | $28.1K Sale | Form 4 ↗ |
| Feb 11, 2026 | Hunter C. Smith Chief Financial Officer | RYTM Rhythm Pharmaceuticals, Inc. | Sale | 100 | $100.85 | $10.1K Sale | Form 4 ↗ |
| Feb 11, 2026 | Hunter C. Smith Chief Financial Officer | RYTM Rhythm Pharmaceuticals, Inc. | Sale | 400 | $99.44 | $39.8K Sale | Form 4 ↗ |
| Feb 11, 2026 | Hunter C. Smith Chief Financial Officer | RYTM Rhythm Pharmaceuticals, Inc. | Sale | 2,266 | $98.37 | $222.9K Sale | Form 4 ↗ |
| Feb 10, 2026 | Hunter C. Smith Chief Financial Officer | RYTM Rhythm Pharmaceuticals, Inc. | Sale | 100 | $104.76 | $10.5K Sale | Form 4 ↗ |
| Feb 10, 2026 | Hunter C. Smith Chief Financial Officer | RYTM Rhythm Pharmaceuticals, Inc. | Sale | 700 | $103.68 | $72.6K Sale | Form 4 ↗ |
| Feb 10, 2026 | Hunter C. Smith Chief Financial Officer | RYTM Rhythm Pharmaceuticals, Inc. | Sale | 1,913 | $102.66 | $196.4K Sale | Form 4 ↗ |
| Feb 5, 2026 | Hunter C. Smith Chief Financial Officer | RYTM Rhythm Pharmaceuticals, Inc. | Sale | 3,381 | $106.06 | $358.6K Sale | Form 4 ↗ |
| Feb 4, 2026 | Hunter C. Smith Chief Financial Officer | RYTM Rhythm Pharmaceuticals, Inc. | Sale | 747 | $107.67 | $80.4K Sale | Form 4 ↗ |
| Feb 4, 2026 | Hunter C. Smith Chief Financial Officer | RYTM Rhythm Pharmaceuticals, Inc. | Sale | 1,000 | $106.60 | $106.6K Sale | Form 4 ↗ |
| Feb 4, 2026 | Hunter C. Smith Chief Financial Officer | RYTM Rhythm Pharmaceuticals, Inc. | Sale | 1,500 | $104.74 | $157.1K Sale | Form 4 ↗ |
| Dec 11, 2025 | Pamela J. Cramer Chief Human Resources Officer | RYTM Rhythm Pharmaceuticals, Inc. | Sale | 3,350 | $111.00 | $371.9K Sale | Form 4 ↗ |
| Nov 20, 2025 | Pamela J. Cramer Chief Human Resources Officer | RYTM Rhythm Pharmaceuticals, Inc. | Sale | 3,350 | $105.00 | $351.8K Sale | Form 4 ↗ |
| Nov 10, 2025 | Pamela J. Cramer Chief Human Resources Officer | RYTM Rhythm Pharmaceuticals, Inc. | Sale | 3,515 | $100.00 | $351.5K Sale | Form 4 ↗ |
| Nov 7, 2025 | Pamela J. Cramer Chief Human Resources Officer | RYTM Rhythm Pharmaceuticals, Inc. | Sale | 19,351 | $98.82 | $1.9M Sale | Form 4 ↗ |
Full history on every feed is part of Premium. Premium loads older rows, up to 10,000, and CSV downloads.
The newest 50 items, most recent first. Every row links to its original filing. Updated Nov 15, 2026, 4:59 PM EST.
Download CSV The rows of this feed, with the filters above. A download holds at most 10,000 rows; narrow the filters to get a smaller slice.
Other feeds: Congressional trades · Executive-branch trades · Bills in Congress · Roll-call votes · Corporate PAC donations · Lobbying · Capitol Hires · Lobbying and contracts · Government contracts · Planned insider sales · Executive pay · Ownership stakes (13D / 13G) · Institutional holdings (13F) · Short interest · Fails to deliver · Daily short volume · Wikipedia page views · App store ratings · H-1B visa applications · Stock splits · 8-K events · IPO filings · Deals · Private placements (Form D) · Merger clearances (HSR) · Layoff notices (WARN) · SEC enforcement · Patents · Clinical trial updates · FDA approvals and clearances